EXHIBIT 23.1
Published on October 8, 2024
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated June 21, 2024, with respect to the consolidated financial statements of Acasti Pharma Inc., incorporated herein by reference.
/s/ KPMG LLP
Philadelphia, Pennsylvania
October 8, 2024